BenzingaOctober 14, 2026 at 6:19 AM NY13 Days Ago
RBC Capital Maintains Outperform on Xylem, Lowers Price Target to $135
RBC Capital analyst Jeffrey Reive maintains Xylem (NYSE:XYL) with a Outperform and lowers the price target from $164 to $135.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
